Transaminase biocatalysts

US10160985B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10160985-B2
Application numberUS-201815915437-A
CountryUS
Kind codeB2
Filing dateMar 8, 2018
Priority dateFeb 26, 2009
Publication dateDec 25, 2018
Grant dateDec 25, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates to polypeptides having transaminase activity, polynucleotides encoding the polypeptides, and methods of using the polypeptides.

First claim

Opening claim text (preview).

What is claimed is: 1. A recombinant polynucleotide encoding a recombinant transaminase polypeptide comprising an amino acid sequence at least 90% identical to SEQ ID NO:110, wherein said recombinant transaminase polypeptide is capable of converting 4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-one (“ketoamide substrate”) to (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine (“product”) under a defined reaction condition in the presence of an amino group donor isopropylamine to levels of the product detectable by HPLC-UV at 210 nm, where the reaction condition comprises about 2 g/L ketoamide substrate, about 0.5 M isopropylamine, about 22° C., about pH 7.5, about 5% DMSO, about 100 μM pyridoxal phosphate, and about 20 mg/mL of transaminase polypeptide. 2. The recombinant polynucleotide encoding the recombinant transaminase polypeptide of claim 1 , wherein said recombinant transaminase polypeptide is capable of converting the ketoamide substrate to the product with an activity that is equal to or greater than the activity of the polypeptide of SEQ ID NO: 4 under the defined reaction condition. 3. The recombinant polynucleotide encoding the recombinant transaminase polypeptide of claim 1 , wherein said recombinant transaminase polypeptide is capable of converting the ketoamide substrate to product in at least 90% enantiomeric excess. 4. The recombinant polynucleotide encoding the recombinant transaminase polypeptide of claim 1 , wherein said recombinant transaminase polypeptide is capable of converting the ketoamide substrate to product in at least 99% enantiomeric excess. 5. The recombinant polynucleotide encoding the recombinant transaminase polypeptide of claim 1 , wherein said recombinant transaminase polypeptide is capable of converting the ketoamide substrate to product with at least 50 to 100 times or greater activity than the polypeptide of SEQ ID NO:4. 6. The recombinant polynucleotide encoding the recombinant transaminase polypeptide of claim 1 , wherein said encoded recombinant transaminase polypeptide is capable of converting the ketoamide substrate to product with at least 1.1 to 5 times or greater activity than the polypeptide of SEQ ID NO:22, 48, or 58. 7. The recombinant polynucleotide of claim 1 , comprising a polynucleotide sequence at least 90% identical to SEQ ID NO:109. 8. An expression vector comprising the recombinant polynucleotide of claim 1 . 9. The expression vector of claim 8 , further comprising at least one control sequence. 10. The expression vector of claim 9 , wherein said control sequence comprises a promoter. 11. The expression vector of claim 9 , wherein said control sequence comprises a secretion signal. 12. A host cell comprising the expression vector of claim 9 . 13. The host cell of claim 12 , wherein said host cell is a bacterial cell. 14. The host cell of claim 13 , wherein said bacterial cell is E. coli.

Assignees

Inventors

Classifications

  • Beta-alanine-pyruvate transaminase (2.6.1.18) · CPC title

  • C12P17/182Primary

    Heterocyclic compounds containing nitrogen atoms as the only ring heteroatoms in the condensed system (alloxazine or isoalloxazine, e.g. riboflavine C12P25/00) · CPC title

  • transferring nitrogenous groups (2.6) · CPC title

  • Amines; Imines · CPC title

  • using catalysts, e.g. selective catalysts · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10160985B2 cover?
The present disclosure relates to polypeptides having transaminase activity, polynucleotides encoding the polypeptides, and methods of using the polypeptides.
Who is the assignee on this patent?
Codexis Inc
What technology area does this patent fall under?
Primary CPC classification C12P17/182. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).